Cepheid Developing Broad-Range Blood Culture Bacterial ID Test for GeneXpert System
November 11, 2010
Cepheid Developing Broad-Range Blood Culture Bacterial ID Test for GeneXpert System
The assay, which is based on melt curve analysis, can currently detect and discriminate between nearly 40 important clinical bacterial species, and may eventually be able to test for more than 100 such species, according to the project's lead scientist.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cepheid Recalls MRSA Blood Culture Test for Second Time; Company, Analysts Unconcerned
January 12, 2012 / PCR Insider - Great Basin Begins Clinical Trial for C. Difficile Test on Automated MDx Platform
June 30, 2011 / PCR Insider - Great Basin Moving POC MDx Platform to Market; Eyes Summer Clinical Trials for First Two Tests
February 17, 2011 / PCR Insider - Roche, Cepheid Execs Wrangle over Clinical Market for PCR-based MRSA Tests
July 29, 2010 / PCR Insider - More Trouble for Cepheid MRSA Test as Abaxis Sues for Patent Infringement
July 15, 2010 / PCR Insider